Systemic inflammation, as indicated by elevated levels of cytokines like interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP), plays a critical role in endothelial dysfunction, microvascular rarefaction, and structural myocardial alterations [6-9]. Here, IL6 is linked to endothelial dysfunction.